| 产品描述: | NYX-2925 is an orally active NMDAR modulator. NYX-2925 restores levels of activated Src and Src phosphorylation sites on GluN2A and GluN2B in the mPFC. NYX-2925 shows no effect on CAMKII, and any addictive or sedative/ataxic side effects. NYX-2925 can be used for research of a variety of NMDA receptor-mediated central nervous system disorders. |
| 靶点: |
NMDA Receptor |
| 保存条件: |
-80°C 6个月; -20°C 1个月,避光,氮气保存 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.363 ml |
16.815 ml |
33.63 ml |
| 5 mM |
0.673 ml |
3.363 ml |
6.726 ml |
| 10 mM |
0.336 ml |
1.682 ml |
3.363 ml |
| 50 mM |
0.067 ml |
0.336 ml |
0.673 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |